Han Biomedical

Han Biomedical Dividend

The Dividend of Han Biomedical (6999.TWO) as of Nov 5, 2026 is 0.39 TWD.

Dividend

0.39TWD

Dividend yield

1.55 %

Last updated:

How much dividend does Han Biomedical 2026 pay?

According to the latest status from November 2026, Han Biomedical paid a total of 0.39 TWD per share in dividends within the last 12 months. With the current Han Biomedical price of 25.20 TWD, this corresponds to a dividend yield of 1.55 %. A dividend is paid times per year.

Han Biomedical currently offers a dividend yield of about 1.55%. The payout ratio is around 35% of earnings.

Historical Han Biomedical Dividends

A dividend is paid times per year. Last year, the payout months were and September.

Historical Han Biomedical Dividends
PaydateDividend
0.57TWD
0.39TWD

The Han Biomedical Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2022
0.00 TWD
Jan 1, 2023
0.00 TWD
Jan 1, 2024
0.39 TWD
The Han Biomedical Dividend history
YEARDividendYoY
0.39TWD—
0.00TWD—
0.00TWD—

Is the Han Biomedical Dividend Safe?

Han Biomedical has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Han Biomedical dividend payout ratio

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2022
34.75 %
Jan 1, 2023
34.75 %
Jan 1, 2024
34.75 %

Dividend Details

Understanding Han Biomedical's Dividend Distributions

Han Biomedical’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Han Biomedical's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Han Biomedical's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Han Biomedical’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Han Biomedical Stock analysis

What does Han Biomedical do? Han Biomedical Inc generates revenue through the design, development, and production of medical materials for tissue reconstruction and repair. Its primary products are BarriGel, a post-surgical anti-adhesion solution that prevents complications by extending degradation time, and Hancare, a collagen scaffolding material made from medical-grade collagen that adheres to wounds and absorbs exudate. The company distributes these products mainly within Taiwan's domestic market, targeting healthcare providers and medical facilities that require advanced tissue repair solutions. The firm focuses on natural biomedical materials, emphasizing product innovation for post-surgical care. BarriGel and Hancare are positioned as specialized medical solutions for wound management and adhesion prevention, catering to hospitals and clinics seeking effective tissue repair technologies. Revenue streams are derived from direct sales of these branded products to domestic healthcare institutions without external distribution channels. Han Biomedical Inc's business model centers on proprietary medical materials developed for specific clinical applications. The company's product portfolio includes BarriGel and Hancare, both designed to address post-surgical challenges with natural materials. Domestic market distribution ensures consistent revenue from local healthcare providers who prioritize advanced tissue repair solutions. Han Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Han Biomedical stock

Over the past 12 months, Han Biomedical paid a dividend of 0.39 TWD . This corresponds to a dividend yield of about 1.55 %. For the coming 12 months, Han Biomedical is expected to pay a dividend of 0.39 TWD.

The current dividend yield of Han Biomedical is 1.55 %.

Han Biomedical paid dividends every year for the past 2 years.

For the upcoming 12 months, dividends amounting to 0.39 TWD are expected. This corresponds to a dividend yield of 1.55 %.

Han Biomedical is assigned to the 'Health' sector.

To receive the latest dividend of Han Biomedical from 9/12/2025 amounting to 0.57 TWD, you needed to have the stock in your portfolio before the ex-date on 8/7/2025.

The last dividend was paid out on 9/12/2025.

In the year 2024, Han Biomedical distributed 0.39 TWD as dividends.

The dividends of Han Biomedical are distributed in TWD.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

All Key Metrics — Han Biomedical